Vor Bio Announces New Clinical Data from Its Ongoing Phase 1/2 VBP101 Study of Patients ...

Retrieved on: 2024-09-06 19:46:24

Tags for this article:

Click the tags to see associated articles and topics

Vor Bio Announces New Clinical Data from Its Ongoing Phase 1/2 VBP101 Study of Patients .... View article details on hiswai:

Excerpt

Logo Vor Biopharma Inc. Vor Biopharma Inc. is a clinical-stage cell and genome engineering therapy company. The Company is engaged in combining a ...

Article found on: www.marketscreener.com